Share on LinkedInShare on LinkedIn

ARTICLE · 21 JANUARY 2021

Brand Owners Encounter High Threshold To Register Single-Color Marks

Fross Zelnick Lehrman & Zissu, P.C.
Fross Zelnick Lehrman & Zissu, P.C.
Contributor
Fross Zelnick Lehrman & Zissu, P.C.

Fross Zelnick Lehrman & Zissu, P.C.

At Fross Zelnick, we secure and defend our clients’ most valuable assets—their brands, designs, and...

View firm profile
Explore more from Fross Zelnick Lehrman & Zissu, P.C.

Two recent decisions by the EU General Court and the IP High Court of Japan demonstrate the very high bar that brand owners face in registering a mark consisting exclusively of a single color.

European UnionIntellectual Property

Two recent decisions by the EU General Court and the IP High Court of Japan demonstrate the very high bar that brand owners face in registering a mark consisting exclusively of a single color.

I. European Union

Background: In 2015, Glaxo Group Ltd ("Glaxo") filed an application for a single-color mark consisting of a shade of purple, which designated "pharmaceutical preparations for the treatment of asthma and/or chronic obstructive pulmonary disease" in Class 5 and inhalers in Class 10.  The EUIPO rejected the application as being devoid of distinctive character. Glaxo subsequently submitted evidence of acquired distinctiveness, and the application was accepted by the EUIPO for publication.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from